H&H Group publishes 2025 annual report, returns to net profit of RMB 196 million
- H&H annual report for year ended Dec. 31, 2025 flagged a return to broad-based growth across adult, baby, pet nutrition businesses.
- Adult nutrition momentum strengthened in Chinese mainland on product innovation, while corporate daigou exposure in Australia and New Zealand was reduced as part of channel strategy reset.
- Baby nutrition regained traction in Chinese mainland following completion of new “GB” infant formula transition by June 2025.
- Pet nutrition expanded as a larger growth driver, supported by continued push into higher-margin supplements.
- Balance-sheet priorities stayed centered on deleveraging, supported by debt reduction in 2025 and further voluntary prepayments totaling about RMB 500 million in Feb.-Mar. 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Health and Happiness (H&H) International Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260410-12101567), on April 10, 2026, and is solely responsible for the information contained therein.
